T Schlaiss, L Bott, S-L Herbert, C Bartmann, M Kiesel, J Salmen, S T Sauer, S A Christner, B Petritsch, J-P Grunz, A Woeckel, S Löb, J Diessner
PURPOSE: Isolated locoregional recurrence of breast cancer (ILRR) and contralateral breast cancer (CBC) affect up to 20% of all breast cancer (BC) patients in the first 20 years after primary diagnosis. Treatment options comprise surgical interventions and further systemic therapies depending on the histological subtype. Patients with hereditary breast or ovarian cancer (HBOC) undergo MRI, mammography, and ultrasound in the aftercare of BC, while non-HBOC (nHBOC) patients do not regularly receive MRI...
April 17, 2024: Journal of Cancer Research and Clinical Oncology